Clinical Trials Browser

Phase 2 × Extensive Stage Small Cell Lung Carcinoma × pembrolizumab × Clear all

NCT02359019 2022-10-14

MK-3475 as Maintenance Therapy in Extensive Stage SCLC

Phase 2 Completed

45 enrolled 10 charts

Extensive Stage Small Cell Lung Carcinoma

NCT03402880 2018-10-10

ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Withdrawn

Extensive Stage Small Cell Lung Carcinoma